aTyr Pharma, Inc. (ATYR) vs Dyadic International Inc. (DYAI)
- aTyr Pharma, Inc. ATYR 0.17 −5.56%
- Dyadic International Inc. DYAI 0.41 −2.38%
aTyr Pharma, Inc. and Dyadic International Inc. are both Biotechnology companies. aTyr Pharma, Inc. and Dyadic International Inc. are of similar size ($18.0M and $16.8M). aTyr Pharma, Inc. grew revenue faster over the last twelve months: 6.78% against −8.05%. aTyr Pharma, Inc. has the higher net margin (0.00% vs −200.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, aTyr Pharma, Inc. leads on 9 and Dyadic International Inc. on 7.
Valuation
Profitability
| Metric | ATYR | DYAI | Biotechnology median |
|---|---|---|---|
| Gross margin | 1.72% | 16.24% | 65.16% |
| Operating margin | 0.00% | (195.47%) | 0.00% |
| Net margin | 0.00% | (200.46%) | 0.00% |
| Free cash flow margin | 0.00% | (194.73%) | 0.00% |
| Return on equity | (98.67%) | 522.58% | (56.36%) |
| Return on assets | (70.97%) | (103.88%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack